AAMC Director on NIH cuts: "Health Will Suffer"

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
This is a preview of Access Health—Tap here to get this newsletter delivered straight to your inbox.
I'm back from my week-long stint in the Mediterranean, which was spent marveling over fresh tomatoes, velvety olive oil and coastlines worthy of a storybook. Although my managing editor may have been skeptical, I truly meant it when I told him I was happy to be back at work. There's a lot going on in U.S. health care right now, and even ~4,700 nautical miles of distance couldn't get the news off my mind.
One conversation in particular has been consuming my thoughts over the past several days. On May 27, I spoke with Dr. Sarah Rossetti, associate professor of biomedical informatics and nursing at Columbia University Irving Medical Center in New York City. The government recently cancelled $400 million in federal funding to the university—bringing her 15-year research project to an abrupt halt.
Rossetti had been working on the CONCERN Study, which had successfully developed an AI model to detect patient deterioration in the hospital setting. The model could identify risk two days earlier than other models that had attempted to predict bad outcomes; CONCERN differentiated itself by tapping into nurses' practices and detecting patterns of concern in their documentation.
The study had been receiving funding from the National Institutes of Health (NIH) for about nine years, and had just published its largest research paper to date in Nature Medicine—demonstrating that throughout a multi-site clinical trial, the AI model had decreased mortality risk by 35 percent, cut sepsis risk by 7.5 percent and shortened length of stay by more than half of a day.
Then, on a Monday night in March—at around 10 p.m.—the government email came through, alerting Rossetti's team that their funding was slashed.
The email did not give any reasoning or provide clarity on the cuts, Rossetti said. She thought that the word "bias," an important scientific consideration for the evaluation of AI models, may have been confused for a DEI concept and flagged by the Trump administration.
"There's really nothing controversial in the work that we're doing, the methods we're using," she told me. Newsweek reached out to the NIH on Wednesday afternoon and will update the web version of this newsletter if we receive a comment.
Although the research team is exploring new funding avenues, it won't happen overnight, Rossetti added. It takes a long time to submit one grant proposal, and it took three tries to get the original NIH funding for the CONCERN Study. Leaders fear that they won't be able to sustain their teams in the interim—and not just at Columbia, but at academic medical centers across the country.
Yesterday, the Association of American Medical Colleges (AAMC) put out a report addressing the cumulative impact of the federal government's actions on academic medicine. So far in 2025, the administration has terminated 1,183 grants and $2 billion of biomedical research funding from U.S. medical schools and hospitals. It also flagged that 50 percent of medical students' loans could be in jeopardy, and critical services that are often provided by academic medical centers—like burn centers, psychiatric services and trauma centers—could be at risk.
"The infrastructure that is required to keep an academic medical center moving forward relies on a partnership with the federal government that is closely linked to research, to medical education and to clinical care," Heather Pierce, Senior Director for Science Policy at the AAMC, told me. "And so as different parts of the mission are impacted, you have to rely on other [parts]. That changes an institution's focus and what they can staff, what they can move forward. All of those specialty areas are potentially at risk."
There's no substitute for that partnership, Pierce said (as so many other health care executives and researchers have agreed).
I've begun conceptualizing all this as a game of Jenga. Yes, our health care system is historically resilient. Yes, our country's best leaders and brightest minds are at its helm. But there are only so many blocks you can pull before the whole tower tumbles. With each project like Rossetti's that is wriggled from the infrastructure, the foundation becomes increasingly unstable. And with every executive order and every Congressional decision, health care leaders' own moves get more precarious.
You can view the full AAMC report here—and read on to the Pulse Check section for more of my interview with Pierce.
Essential Reading
Hospitals are increasingly standing up digital command centers to improve efficiency and oversight of both in-person and virtual services. In my latest deep dive, I connected with four hospitals to learn how these NASA-esque hubs are improving their operations. Get the scoop here.
HHS has removed all 17 members of the Advisory Committee for Immunization Practices , which is responsible for advising the CDC on vaccine safety and protocol. The 17 sitting members were appointed by the Biden administration. In a HHS news release, Secretary Robert F. Kennedy Jr. said the move was "prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda."
, which is responsible for advising the CDC on vaccine safety and protocol. The 17 sitting members were appointed by the Biden administration. In a HHS news release, Secretary Robert F. Kennedy Jr. said the move was "prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda." But health care leaders and clinicians have expressed grave concerns about the unprecedented action—and its potential impacts on immunization schedules and vaccine accessibility. The director of Brown University's Pandemic Center laid out the possible consequences in an interview with Scientific American.
The Coalition for Health AI (CHAI) has partnered up with the Joint Commission to co-develop AI playbooks, tools and a new certification program for U.S. hospitals and health systems. Their first guidance will be available in the fall of 2025, followed by AI certification. Read more about the partnership here.
to co-develop AI playbooks, tools and a new certification program for U.S. hospitals and health systems. Their first guidance will be available in the fall of 2025, followed by AI certification. Read more about the partnership here. If you're interested in learning more about CHAI's work, I encourage you to watch Newsweek's recent webinar on AI governance, featuring CEO Dr. Brian Anderson.
UnitedHealth Group's saga continues as the health care giant considers bids that would allow it to exit from Latin America, Reuters reported on Monday. The company lost more than $8 billion in the market last year and has been trying to leave it since 2022—but the situation has grown more urgent in recent months amid leadership shakeups, criminal probes and public discontent, per two unnamed sources.
Pulse Check
Heather Pierce is the senior director for science policy at the Association of American Medical Colleges.
Heather Pierce is the senior director for science policy at the Association of American Medical Colleges.
AAMC
Usually, I do a Pulse Check with a CEO in the industry—but this week, I felt that the AAMC's report deserved some extra attention. Below, find a portion of my interview with Heather Pierce, Senior Director for Science Policy at the AAMC.
Editor's Note: Responses have been edited for length and clarity.
Heather, the report details a number of critical programs that academic medical centers rely on—and that are currently at risk of being cut by the federal government. When you talk to your member organizations about all of these issues, what are their reactions? What are their primary concerns right now?
The mission of academic medicine is to improve the health of all.
Leaders of institutions are looking at these changes, these actions that are impacting their institutions—some in ways that they can understand and calculate, and some that at this point are still highly speculative. But when put together, [these changes] will cause those institutions to have to make difficult choices about where they focus their resources and attention.
It's not just about the institution, because those institutions, of course, have an impact on their local economy. They're usually main economic drivers of the area around them. When we look at the cumulative effect across all institutions, we realize that ultimately, health will suffer and health will not improve in the way that it could. The research that takes place at one institution has potential benefits for the individuals that are there, that are involved in those clinical trials and other research. But the results of that research, of course, are not limited in any way to the patients of that institution or that local area or that state, but are used to develop clinical guidelines and best practices that are implemented nationwide. All of that is at risk now.
Have your members been able to forecast the potential impacts of cuts in each of these areas, from Medicaid to scientific research? Are they making any proactive changes or taking preventative measures?
They're all engaged in predictive modeling, trying to figure out exactly what is happening and what the impact would be for each of them. At this moment, it differs from institution to institution. Some institutions have been directly targeted.
Some have seen bigger cuts than others to their research mission, and many have been forced to make really difficult and devastating decisions about their future workforce—how many graduates should they be taking on next year if half of their NIH grants are cut? What happens with the postdoctoral scholars that are here on international visas, or those that are that are helping to contribute to labs whose funding is in question? Those kinds of decisions are being made on a day-to-day basis, while institutions are doing their best to preserve the current and future generations of physicians, scientists and educators.
C-Suite Shuffles
Allison Viramontes is the new CFO of Jupiter Medical Center . She joins the independent Florida health system from Mayo Clinic Arizona, where she most recently served as CFO.
is the new of . She joins the independent Florida health system from Mayo Clinic Arizona, where she most recently served as CFO. Sutter Health , based in Sacramento, California, has named Dr. Ashley Beecy its chief AI officer . She previously worked as medical director of AI operations at NewYork-Presbyterian.
, based in Sacramento, California, has named its . She previously worked as medical director of AI operations at NewYork-Presbyterian. Dr. John Whyte has stepped down from his role as chief medical officer at WebMD to become CEO of the American Medical Association.
Executive Edge
Sach Jain is the founder and CEO of Carrum Health.
Sach Jain is the founder and CEO of Carrum Health.
Carrum Health
Sach Jain is the founder and CEO of Carrum Health, a value-based care platform providing specialty care through a Centers of Excellence (COE) network. Under Jain's leadership, the company has grown to include more than 1,100 COEs since 2014 and has helped employers curb the cost of specialty care procedures by up to 45 percent.
In addition to leading Carrum Health and navigating the complicated payer-provider ecosystem, Jain is a parent, and travels frequently to headline executive roundtables and industry conferences. This week, I asked how he maintains healthy habits and balance within his schedule.
He told me that he works to incorporate lifestyle habits across three pillars: nutrition, exercise, and mental health. Here's what he does to keep them all in check:
Nutrition: "I start most days—five or six days a week—with oatmeal. It's become a reliable routine. For lunch during the workweek, I go for salads as much as possible. I tend to eat small portions overall. When I travel and it's difficult to avoid fancy meals, eating small portions is really helpful. Dinner is usually home-cooked during the week, and we often will eat out on weekends. I call it collecting points during the week and spending them on the weekend. I also avoid eating after 8 p.m. to ensure I give myself the best chances of a restful, full night's sleep. I love my wine but limit alcohol to just one drink a week, even in social settings and while traveling."
"I start most days—five or six days a week—with oatmeal. It's become a reliable routine. For lunch during the workweek, I go for salads as much as possible. I tend to eat small portions overall. When I travel and it's difficult to avoid fancy meals, eating small portions is really helpful. Dinner is usually home-cooked during the week, and we often will eat out on weekends. I call it collecting points during the week and spending them on the weekend. I also avoid eating after 8 p.m. to ensure I give myself the best chances of a restful, full night's sleep. I love my wine but limit alcohol to just one drink a week, even in social settings and while traveling." Exercise: "I run about three times a week for about an hour— usually along the coast in San Diego. I typically use that time to listen to podcasts and that's my best trick to tune out from work. We also have a basic gym at home that I use a few times a week, focusing on weights and stretching. On days I don't run, I usually take a long walk after dinner. I also try to hit a few tennis balls when the schedule allows."
"I run about three times a week for about an hour— usually along the coast in San Diego. I typically use that time to listen to podcasts and that's my best trick to tune out from work. We also have a basic gym at home that I use a few times a week, focusing on weights and stretching. On days I don't run, I usually take a long walk after dinner. I also try to hit a few tennis balls when the schedule allows." Mental Health: "I give myself digital silence from Friday evening to Sunday morning—no emails or Slack. Sunday afternoons are for planning, reflection, and deep work. I've followed this practice for over a decade. It started during my consulting days when Monday [to] Thursday were always travel days, so you had to get your ducks in a row on Sunday before you took off on Monday morning. I spend time with my family in the mornings before school, and we eat dinner together most nights. I make sure that Saturdays and Sunday mornings are fully reserved for family and friends.
"I give myself digital silence from Friday evening to Sunday morning—no emails or Slack. Sunday afternoons are for planning, reflection, and deep work. I've followed this practice for over a decade. It started during my consulting days when Monday [to] Thursday were always travel days, so you had to get your ducks in a row on Sunday before you took off on Monday morning. I spend time with my family in the mornings before school, and we eat dinner together most nights. I make sure that Saturdays and Sunday mornings are fully reserved for family and friends. I avoid days packed with non-stop meetings—they can be exhausting and unproductive. As Carrum has grown, my role has also evolved. I'm more selective now about where I devote time. I try to shoot for fewer but more meaningful meetings, as much as possible."
This is a preview of Access Health—Tap here to get this newsletter delivered straight to your inbox.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Miami Herald

20 hours ago

• Miami Herald

Some Johns Hopkins, UMD research stopped after Trump cuts. Others are scrambling to resume

BALTIMORE - Some Maryland university research projects on the Trump administration's chopping block have been fully discontinued, while others are scrambling to resume after a pause in funding. Johns Hopkins has lost more than $800 million in federal grant money. The University of Maryland lost tens of millions of dollars. But some cuts have been blocked by legal challenges, though litigation is ongoing. Researchers describe disappointment and uncertainty as they determine how to move forward. Alternative funding has been secured for a clinical trial in Bangladesh aimed at managing life-threatening diarrheal diseases in children, which was previously halted because of U.S. Agency for International Development funding cuts. The work has yet to resume. "It just takes a long time to rebuild the teams and get things in place again to start," said Judd Walson, chair of the Department of International Health at Johns Hopkins University, which partnered on the project. "The disruptions that are happening are really catastrophic." Over the past several weeks, 17 NIH awards have been terminated or had an unclear status, including two training awards supporting doctoral-level researchers, Walson said. "We're not getting a lot of communication, so it's a little bit hard to say exactly what the status of some of these awards are," he said. The National Institutes of Health didn't respond to questions about funding cuts to Maryland research institutions. In a lawsuit challenging NIH research cuts, lawyers for the federal government wrote in a recent court filing that its terminations of grants for DEI-related studies were "sufficiently reasoned," and that the NIH has "broad discretion" to decide what grants to provide. Johns Hopkins is a plaintiff in two lawsuits involving caps on reimbursement of indirect costs for research - one challenging the NIH and the other against the Department of Defense. The latter suit also lists the University of Maryland, College Park, as a plaintiff. Both schools have also filed a brief in support of a lawsuit filed by Harvard University against the Trump administration's funding cuts. New grant terminations have been arriving "nearly every week," Johns Hopkins University said in a recent update published on its website. There's also been a nearly two-thirds decrease in new awards compared with last year, the university said. Johns Hopkins atmosphere and ocean sciences researcher Darryn Waugh was disappointed upon receiving notice that his NASA grant to study air pollution in Baltimore was canceled by the Trump administration. The termination came as a result of President Donald Trump's executive order, "Ending Radical and Wasteful Government DEI Programs and Preferencing." "It wasn't clear to me that this actually falls under this diversity, equity, inclusion," Waugh said. "It was research that I think we still wanted to do - to understand how the air pollution varies through the city - and the environmental justice was only actually a relatively small component of it." Waugh was working through the second year of a three-year grant, totaling $1,465,950. "We've got kind of a preliminary analysis," he said, regarding the research. "But to get anything conclusive, we would need more than one year of funding." Waugh said he intends to find ways of continuing the research without the NASA grant. Daniel Mullins, at the University of Maryland School of Pharmacy, had a grant canceled for a "Health Equity Research Hub," which examined how to encourage greater participation in health-related research. Mullins said the loss of the grant affected five positions, and the individuals will be removed from the university because of lack of funding. He added that the termination stated that the grant was DEI-related, which he disputes. "I think under the DEI umbrella, a lot of times, the government will refer to it as just one racial ethnic group," he said. "We've worked in different geographies, in different racial and ethnic populations, but what's cool about what we do is it really does apply to all patients in all populations." Mullins said his research group has additional funding from other agencies and is writing new proposals. Walson said social determinants of health - involving factors like poverty and other "inequities" - are "foundational to our understanding of health." "So the idea that we would not be able to pursue work that focuses on identifying and managing those particular issues, which are the underlying, core issues at the heart of health issues, is really challenging," Walson said. The Trump administration's cuts have had an ieffect across the world. Walson said it's estimated the cuts will result in hundreds of thousands of deaths globally, and could eventually lead to millions of deaths over the next couple of years. Secretary of State Marco Rubio has said it's "a lie" that people have died because of USAID cuts. During a congressional hearing in May, Rubio said the U.S. is the world's "largest humanitarian provider." "I would argue: How many people die because China hasn't done it?" he said. "How many people have died because the U.K. has cut back on spending and so has other countries?" Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.

E&E News

a day ago

• E&E News

NIH commits $10M for health studies at site of 2023 derailment

The National Institutes of Health announced funding Thursday for long-term health research in East Palestine, Ohio, where a train derailment spilled almost 2 million pounds of hazardous chemicals in 2023. Over the next five years, NIH will spend $10 million to study health problems being reported by East Palestine residents. 'This funding will enable the people of East Palestine to have the peace of mind that comes from knowing that any potential for long-term health effects will be studied by the scientists at the National Institutes of Health,' Ohio Gov. Mike DeWine (R) said in a news release. Advertisement East Palestine residents have expressed concern about hydrogen chloride and phosgene exposure after the controlled burning of seven rail cars following the accident. There are worries about asthma, headaches and respiratory irritation.

UPI

2 days ago

• UPI

NIH office to phase out HIV guidelines by next year

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States is making major changes. File Photo by Annabelle Gordon/UPI | License Photo June 21 (UPI) -- The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States is making major changes. The NIH Office of AIDS Research or OAR told its employees this week it intends to phase out the guidelines by next June, the Washington Post reported, citing an internal staff email. According to the office, OAR "coordinates HIV/AIDS research across the National Institutes of Health and provides the largest public investment in HIV/AIDS research globally." "In the climate of budget decreases and revised priorities, OAR is beginning to explore options to transfer management of the guidelines to another agency within" the letter obtained by The Post reads. The OAR guidelines contain guidelines related to diagnosis and treatments of HIV and AIDS. There are currently more than 1 million people living with HIV in the United States. It was not immediately clear what the other agency referred to in the letter was or how such a move may affect the guideline, the Post reported. The news comes as President Donald Trump and Secretary of State Marco Rubio move to cut over $8 billion from the U.S. Agency for International Development, USAID and merge it into the State Department. State Department officials say the move comes with the expectation that other countries will increase their roles in delivering aid around the world. An April report published in the Lancet medical journal found around half a million children globally could die from AIDS by 2030 if the United States cuts its global relief funding. Earlier this week, the U.S. Food and Drug Administration approved use of the HIV drug lenacapavir, which is produced by California-based biopharma firm Gilead Sciences under the name Yeztugo. "Yeztugo is one of the most important scientific breakthroughs of our time and offers a very real opportunity to help end the HIV epidemic," Gilead Science Chairman and Chief Executive Officer Daniel O'Day said in a statement on the company's website